NOT-CA-17-027: Notice of Expiration of PAR-16-105 "Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)"

Notice of Expiration of PAR-16-105 "Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)"

Notice Number: NOT-CA-17-027

Key Dates
Release Date: January 27, 2017

Related Announcements
PAR-16-105

Issued by
National Cancer Institute (NCI)

Purpose

This Notice is to inform the research community of the expiration of PAR-16-105 "Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)" effective immediately. Therefore, U01 applications will not be accepted for the May 30, 2017 Application Due Date and all subsequent application due dates in PAR-16-105.

The NCI intends to issue a funding opportunity announcement of similar scope in the near future.

Inquiries

Please direct all inquiries to:

Nastaran Z. Kuhn, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7610
Email: [email protected]